17-1728074-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001163809.2(WDR81):c.3115G>A(p.Ala1039Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000444 in 1,587,240 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1039P) has been classified as Uncertain significance.
Frequency
Consequence
NM_001163809.2 missense
Scores
Clinical Significance
Conservation
Publications
- cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- cerebellar ataxia, intellectual disability, and dysequilibriumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152224Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000276 AC: 56AN: 203016 AF XY: 0.000307 show subpopulations
GnomAD4 exome AF: 0.000451 AC: 647AN: 1434898Hom.: 4 Cov.: 34 AF XY: 0.000420 AC XY: 299AN XY: 711934 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000374 AC: 57AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000362 AC XY: 27AN XY: 74506 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Inborn genetic diseases Uncertain:1
The c.3115G>A (p.A1039T) alteration is located in exon 1 (coding exon 1) of the WDR81 gene. This alteration results from a G to A substitution at nucleotide position 3115, causing the alanine (A) at amino acid position 1039 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
Variant summary: WDR81 c.3115G>A (p.Ala1039Thr) results in a non-conservative amino acid change in the encoded protein sequence. Two of three in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00045 in 1580346 control chromosomes, predominantly at a frequency of 0.00056 within the Non-Finnish European subpopulation in the gnomAD database (v4.1 dataset), including 4 homozygotes. To our knowledge, no occurrence of c.3115G>A in individuals affected with Cerebellar Ataxia, Intellectual Disability, And Dysequilibrium Syndrome 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 377255). Based on the evidence outlined above, the variant was classified as likely benign. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at